EEI-BIOTECHFINANCES Eléments Essentiels d'Information / Essential Elements of Information
Friday, March 29th 2019 at 6:03pm UTC CAMBRIDGE, Massachusetts–(BUSINESS WIRE)– Ultivue, un développeur de tests d’identification et de quantification des biomarqueurs tissulaires destinés aux laboratoires de recherche translationnelle et en pathologie, et Definiens, une société pionnière de l’analyse des images basée sur l’intelligence artificielle, ont annoncé aujourd’hui une collaboration visant …
Plus »Definiens and Ultivue Announce a Collaboration to Co-Develop Joint Offerings in Multiplexed Immunofluorescence (IF) and AI Enabled Digital Image Analysis
Friday, March 29th 2019 at 3:11pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Ultivue, a developer of tissue biomarker identification and quantification assays for translational and pathology research labs, and Definiens, a pioneer in artificial intelligence (AI) based image analysis, today announced a collaboration to expand Definiens standardized IO-Panel capabilities to IF. The …
Plus »NorthStar Medical Radioisotopes, LLC Signs Contract with IBA for Eight Rhodotron® Electron Beam Accelerators to Expand U.S. Production of Non-uranium Based Radioisotope Mo-99
Friday, March 29th 2019 at 11:00am UTC – Accelerator technology key component of NorthStar’s multi-pronged Mo-99 production strategy – BELOIT, Wis.–(BUSINESS WIRE)– NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of radioisotopes used for medical imaging, and IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading …
Plus »Magellan Health Announces Agreement with Starboard
Friday, March 29th 2019 at 10:30am UTC Four New Independent Directors to Join Magellan Health Board Starboard Agrees to Support All Magellan Health Nominees at 2019 Annual Meeting SCOTTSDALE, Ariz.–(BUSINESS WIRE)– Magellan Health, Inc. (NASDAQ: MGLN) today announced that it has entered into an agreement with Starboard Value LP (together …
Plus »Applied DNA Announces Exclusive Cannabis Licensing and Cooperation Agreement with Theracann International
Friday, March 29th 2019 at 9:30am UTC – Applied DNA to Receive Staged Payments Totaling $5M Over the Next Four-Months – – Agreement Calls for Annual Payment Minima that Scale from $7 Million in Year 3 to $20 Million in Year 15 – – Applied DNA Technology to Power ETCH …
Plus »Eccrine Systems Announces Collaboration with Maxim Integrated Products
Thursday, March 28th 2019 at 12:45pm UTC CINCINNATI–(BUSINESS WIRE)– Eccrine Systems, Inc. announced today that it is collaborating with Maxim Integrated Products, Inc. (NASDAQ: MXIM) on the development and integration of analog signal processing technologies to drive Eccrine’s sweat sensing platform. Maxim Ventures has invested in Eccrine as part of …
Plus »Tricida Announces $200 Million Debt Facility With Hercules Capital
Thursday, March 28th 2019 at 11:07am UTC SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Tricida, Inc. (Nasdaq: TCDA), a pharmaceutical company focused on the development and commercialization of its drug candidate TRC101 (veverimer), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney disease (CKD), announced today that …
Plus »Prelude Fertility and Inception Establish the Largest Provider of Comprehensive Fertility Services in the U.S.
Thursday, March 28th 2019 at 11:15am UTC New Combined Company Will Dramatically Expand the Quality of Patient Experience and Best-in-Class Care NEW YORK–(BUSINESS WIRE)– Today, Prelude Fertility (Prelude) and Inception Fertility (Inception) announced a transaction establishing the Prelude Network as the fastest-growing network of fertility clinics, and now the largest …
Plus »Oragenics, Inc. Enters into Collaboration with Florida International University to Expand Its Pipeline of Lantibiotics
Wednesday, March 27th 2019 at 12:00pm UTC TAMPA, Fla.–(BUSINESS WIRE)– Oragenics, Inc. (NYSE American:OGEN), a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis (“OM”), today announced the initiation of a collaboration with Florida International University (FIU) to create computational models of the …
Plus »The European Molecular Biology Laboratory Selects HID Global’s Industry-Leading RFID Technology in New Design Standard for Cryogenic Research Equipment
Wednesday, March 27th 2019 at 12:01pm UTC AUSTIN, Texas–(BUSINESS WIRE)– HID Global®, a worldwide leader in trusted identity solutions, today announced that the European Molecular Biology Laboratory (EMBL) in Grenoble, France has selected HID’s radio frequency identification (RFID) tags and its patented direct bonding technology for automated handling of biological …
Plus »
